The "2024-2030 China Blood Cell Separator Industry Market Status Survey and Investment Prospect Research Report" (hereinafter referred to as the "Report") compiled by Zhiyan Consulting is a professional market research report in the field of blood cell separators in China, and is a faithful recorder and witness of the development of the blood cell separator industry. It aims to provide a comprehensive reference for Chinese blood cell separator industry manufacturers, government agencies, and industry experts to understand and grasp the development of China's blood cell separator.
The report has been published annually since 2018 and has been published for seven consecutive years. The "Report" has a total of 7 chapters, from the aspects of industry overview, demand status, market size, channel analysis, major enterprises, technology analysis, development trends, industry research and other aspects, through detailed data, comprehensively summarizes and reviews the new trends and highlights of the blood cell separator industry in 2023, and at the same time conducts in-depth thinking on the existing problems. A series of useful suggestions and future prospects are put forward for the next high-quality development of the blood cell separator industry.
The blood cell separator is a medical device that separates different blood components of whole blood according to the density, viscosity and other characteristics of different blood components by processing whole blood, so as to facilitate the collection of some blood components according to needs. According to the different separation technology principles of blood cell separators, they can be divided into three categories: centrifugal type, filter type and adsorption type. According to statistics, the demand for blood cell separators in mainland China in 2023 will be 1,150 units, and the market size will be 535 million yuan.
The upstream of the blood cell separator industry mainly includes suppliers of raw materials and parts required for blood cell separators. These raw materials and components typically include plastics, metals, electronic components, chemical reagents, and more. The main function of the upstream enterprise is to provide the necessary raw materials and components to the midstream producers, and to ensure that the production and assembly of the blood cell separator can proceed smoothly. Midstream refers to the producers of blood cell separators. The downstream of the industrial chain mainly includes the application fields of blood cell separators, such as blood banks, hospitals, scientific research institutions, etc.
At present, the overall technical level in the field of blood cell separators in mainland China is not high, and high-tech products rely on imports. The main manufacturers of blood cell separators (devices) are Telmo, Fresenius, Nanger, Shanghai Weimei, Weigao, Chengdu Jiaying, Dahua Medical, Zhongbaokang, Kangbei Medical, etc.
Among them, Nanger is mainly engaged in the research and development, production and sales of blood transfusion equipment, disposable consumables and drugs, and is the first to develop a blood component separator, the first to develop a hemorrhagic cell separator, the first to develop a bleeding platelet preservation bag at room temperature, the first to develop a top and bottom bag leukocyte collection transfusion device, the first to develop an intelligent red blood cell processing instrument, and the first to develop a plasma separator with electronic identification function. Weigao Co., Ltd. is mainly engaged in R&D and development, production and sales of disposable medical devices. The main products include infusion (blood) sets, syringes, blood bags and blood component separation consumables, blood collection series consumables, prefilled syringes for pharmaceutical packaging and medical needle products. Chengdu Jiaying is a high-tech enterprise specializing in R&D, production and sales of medical electronic equipment and medical polymer products, computer software research and development, a promoter of the application of domestic component blood transfusion technology, a leader in domestic blood separation technology products, a provider of high-quality blood component collection solutions, and an excellent manufacturer of three types of medical devices in China.
The research team of Zhiyan Consulting conducted an in-depth analysis on the scale, industrial structure, key enterprises, and industrial development trends of China's blood cell separator industry, and put forward suggestions for the problems existing in the development of the blood cell separator industry, providing reference for local governments, industrial chain related enterprises, and investment institutions.
Data Description:
1: The core data of this report has been updated to December 2023 (the relevant financial indicators of non-listed companies in the report are affected by corporate credit approval, and there may be a certain lag), and the forecast period of the report is 2024-2030.
2: In addition to the first-hand research information and data, authoritative data sources such as the National Bureau of Statistics, China Customs, industry associations, and public reports of listed companies (prospectuses, transfer prospectuses, annual reports, inquiry reports, etc.) also constitute the data sources of this report. The first-hand data comes from the first-hand information data obtained by the research team from interviews with key enterprises in the industry, and the main interview subjects include corporate executives, industry experts, technical leaders, downstream customers, distributors, agents, distributors and upstream raw material suppliers. Secondary sources mainly include relevant industry news, company annual reports, non-profit organizations, industry associations, government agencies and third-party databases from around the world.
3: The core data of the report is based on the strict data collection, screening, processing, analysis system and independent calculation model of the Zhiyan team to ensure the accuracy and reliability of statistical data.
4: The data used in this report are all from compliance channels, and the analysis logic is based on the professional understanding of the Zhiyan team, which clearly and accurately reflects the research views of analysts.
As a leading brand in the field of industrial consulting in China, Zhiyan Consulting takes "driving industrial development with information and empowering enterprise investment decision-making" as its brand concept. The company integrates quantitative analysis and qualitative analysis methods, uses self-developed algorithms, combines industry cross-big data, and excavates the root causes behind quantitative data through diversified analysis, analyzes the logic behind qualitative content, objectively and truthfully explains the current situation of the industry, prudently predicts the future development trend of the industry, and provides customers with professional industry analysis, market research, data insights, strategic consulting and related solutions to help customers improve their cognitive level, profitability and comprehensive competitiveness. The main services include high-quality industry research reports, special customization, monthly topics, feasibility study reports, business plans, industrial planning, etc. Provide weekly/monthly/quarterly/annual reports and other regular reports and customized data, covering policy monitoring, corporate dynamics, industry data, product price changes, investment and financing overview, market opportunities and risk analysis, etc.